» Articles » PMID: 9238616

Epidemiology of Renal-cell Carcinoma

Overview
Journal J Nephrol
Publisher Springer
Specialty Nephrology
Date 1997 Mar 1
PMID 9238616
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Renal-cell cancer is responsible for about 2% of all cancer deaths in developed countries and represents 80-85% of all tumors of the kidney. Its etiology is still largely undefined. Recently the results of a large international population-based case-control study (International Renal-Cell Cancer Study), conducted between 1989 and 1991 in Australia, Denmark, Germany, Sweden and USA, including 1732 cases and 2309 controls, showed an increased risk of renal-cell cancer in relation to tobacco smoking, elevated body mass index, a few medical conditions, the use of beta-blockers, a family history of the disease, high intake of dairy products and low intake of fruit and vegetables and, in women, multiparity. Most other studies agree about a causal role of cigarette smoking in the etiology of renal-cell cancer, although its association is less strong than for several other tobacco-related neoplasms, with a relative risk of about 2 for current smokers. Other established risk factors are elevated body mass index (mainly in women) and a family history of the disease. Occupational exposure to chemicals appears to have little significance, although associations with specific products, such as asbestos fibres, have been reported. Some relationship has been observed between renal-cell cancer and hypertension, use of anti-hypertensives and kidney diseases, although this issue remains open to discussion. Data are inconsistent on the role of nutrition, mainly for fats and proteins, while vegetable and fruit consumption seems to convey some protection on renal-cell cancer risk. The risk of renal-cell cancer was not materially elevated in relation to coffee, tea and alcohol intake and, in women, oral contraceptive use, hormone replacement therapy, and menstrual factors.

Citing Articles

Dietary Inflammatory Index and Renal Cell Carcinoma Risk in an Italian Case-Control Study.

Shivappa N, Hebert J, Rosato V, Rossi M, Montella M, Serraino D Nutr Cancer. 2017; 69(6):833-839.

PMID: 28718670 PMC: 6089838. DOI: 10.1080/01635581.2017.1339815.


Oncogenic microRNA-142-3p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.

Li Y, Chen D, Jin L, Liu J, Li Y, Su Z Oncol Lett. 2016; 11(2):1235-1241.

PMID: 26893725 PMC: 4734216. DOI: 10.3892/ol.2015.4021.


Lycopene in the prevention of renal cell cancer in the TSC2 mutant Eker rat model.

Sahin K, Cross B, Sahin N, Ciccone K, Suleiman S, Osunkoya A Arch Biochem Biophys. 2015; 572:36-39.

PMID: 25602702 PMC: 5657428. DOI: 10.1016/j.abb.2015.01.006.


Clinical outcomes and survival of advanced renal cancer patients in phase I clinical trials.

Malik L, Parsons H, Mahalingam D, Ehler B, Goros M, Mejia A Clin Genitourin Cancer. 2014; 12(5):359-65.

PMID: 24582088 PMC: 4492113. DOI: 10.1016/j.clgc.2014.01.011.


Meta-analysis of the diagnostic performance of [18F]FDG-PET and PET/CT in renal cell carcinoma.

Wang H, Ding H, Chen J, Chao C, Lu Y, Lin W Cancer Imaging. 2012; 12:464-74.

PMID: 23108238 PMC: 3483599. DOI: 10.1102/1470-7330.2012.0042.